Research location

Sakura

Japan

Published trials11
Site observations11
Linked trials published11
Page1 / 1
Advertisement

Research activity in Sakura

Japan

CureCurrent currently publishes aggregate city-level research activity for this location: 11 trials and 11 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Sakura

11 linked trials · page 1 of 1
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT07164443 · 2025-09-02 · 1 site observation
RECRUITING
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyNCT03767244 · 2019-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCNCT02489318 · 2015-11-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade TherapyNCT02405858 · 2015-04-10 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT02257736 · 2014-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerNCT01946204 · 2013-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)NCT01715285 · 2013-02-12 · 1 site observation
COMPLETED
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate CancerNCT01756638 · 2012-06-06 · 1 site observation
COMPLETED
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelNCT01795703 · 2012-06-01 · 1 site observation
COMPLETED
Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate CancerNCT01193244 · 2010-10-01 · 1 site observation
COMPLETED
Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term UseNCT01050062 · 2010-01-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.